A Hispanic man in his 50s—recently diagnosed with acral lentiginous melanoma—presented
for evaluation of a tender, photodistributed rash that was first appreciated approximately
10 weeks prior. Review of systems was notable for difficulty lifting objects above
his head.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Risk of malignancy in dermatomyositis and polymyositis.J Cutan Med Surg. 2017; 21: 131-136
- Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.Arthritis Rheum. 2013; 65: 2954-2962
- Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.Lancet. 2001; 357: 96-100
- Dermatomyositis associated with malignant melanoma—A marker of poor prognosis?.J Am Acad Dermatol. 2006; 54: 221-226
Article Info
Publication History
Published online: February 24, 2022
Uma Paniker, MD, Section EditorFootnotes
Funding: None.
Conflict of Interest: None.
Authorship: All authors had access to the data and a role in writing this manuscript
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.